# Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

> **NCT03011450** · PHASE3 · COMPLETED · sponsor: **Kowa Research Institute, Inc.** · enrollment: 471 (actual)

## Conditions studied

- Severe Hypertriglyceridemia

## Interventions

- **DRUG:** K-877
- **DRUG:** Fenofibrate
- **DRUG:** Placebo (for K-877)

## Key facts

- **NCT ID:** NCT03011450
- **Lead sponsor:** Kowa Research Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-26
- **Primary completion:** 2019-07-05
- **Final completion:** 2019-07-05
- **Target enrollment:** 471 (ACTUAL)
- **Last updated:** 2022-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011450, "Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03011450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*